Journal list menu
Export Citations
Download PDFs
ISSUE COVER
Issue Cover
- Page: i
- First Published: 29 December 2021

The cover image is based on the Original Article A novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis by Feng Gao et al., https://doi.org/10.1111/liv.15064.
INSIDE FRONT COVER
Inside Front Cover
- Page: ii
- First Published: 19 January 2022

The cover image is based on the Original Article Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study by Paolo Ventura et al., https://doi.org/10.1111/liv.15090.
BACK COVER
Back Cover
- Page: iii
- First Published: 19 January 2022

The cover image is based on the Brief Definitive Report Rapid detection for infected ascites in cirrhosis using metagenome next-generation sequencing: A case series by Beiling Li et al., https://doi.org/10.1111/liv.15083.
ISSUE INFORMATION
EDITORIAL
Binge drinking and fibrogenesis: More than just a hangover
- Pages: 6-8
- First Published: 29 December 2021
REVIEWS & META-ANALYSES
Gamma-Glutamyl Transferase (γ-GT) – an old dog with new tricks?
- Pages: 9-15
- First Published: 14 November 2021
LIVER DISEASE AND PUBLIC HEALTH
The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia
- Pages: 16-25
- First Published: 30 July 2021
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
- Pages: 26-37
- First Published: 28 September 2021
VIRAL HEPATITIS
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)
- Pages: 38-49
- First Published: 14 September 2021
Maternal and fetal outcomes of pregnancies complicated by acute hepatitis E and the impact of HIV status: A cross-sectional study in Namibia
- Pages: 50-58
- First Published: 08 October 2021
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
- Pages: 59-68
- First Published: 23 October 2021
METABOLIC & TOXIC LIVER DISEASES
Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis
- Pages: 69-79
- First Published: 14 September 2021
A novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis
- Pages: 80-91
- First Published: 26 September 2021
Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3)
- Pages: 92-101
- First Published: 30 November 2021
Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease
- Pages: 102-111
- First Published: 25 November 2021
GUT-LIVER AXIS, IMMUNOLOGY, IMMUNE MEDIATED AND CHOLESTATIC DISEASES
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis
- Pages: 112-123
- First Published: 17 August 2021
Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection
- Pages: 124-134
- First Published: 19 August 2021
The effect of biliary obstruction, biliary drainage and bile reinfusion on bile acid metabolism and gut microbiota in mice
- Pages: 135-148
- First Published: 30 August 2021
GENETICS AND RARE LIVER DISEASES
Association of genetic variations with NAFLD in lean individuals
- Pages: 149-160
- First Published: 05 October 2021
Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study
- Pages: 161-172
- First Published: 30 October 2021
CIRRHOSIS, LIVER FAILURE AND TRANSPLANTATION
Rapid detection for infected ascites in cirrhosis using metagenome next-generation sequencing: A case series
- Pages: 173-179
- First Published: 23 October 2021
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients
- Pages: 180-186
- First Published: 31 October 2021
Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury
- Pages: 187-198
- First Published: 14 November 2021
LIVER CANCER
Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects
- Pages: 199-209
- First Published: 07 September 2021
Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study
- Pages: 210-223
- First Published: 22 October 2021
Risk factors for bleeding hepatocellular adenoma in a United States cohort
- Pages: 224-232
- First Published: 23 October 2021
EXPERIMENTAL HEPATOLOGY
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma
- Pages: 233-248
- First Published: 03 September 2021
RESEARCH LETTERS
Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort)
- Pages: 249-252
- First Published: 26 November 2021
LETTERS TO THE EDITOR
Improvement in adipocytic indices as a predictor of improved outcomes after TIPS: Right conclusion?
- Page: 253
- First Published: 01 November 2021
A typical autoimmune hepatitis (AIH) case following Covid-19 mRNA vaccination. More than a coincidence?
- Pages: 254-255
- First Published: 01 November 2021
Impact of COVID – 19 in patients awaiting liver transplantation
- Pages: 256-257
- First Published: 19 November 2021
Albumin for AKI in cirrhosis – Sham therapy or effective?
- Pages: 258-259
- First Published: 24 November 2021
NAFLD vs ALD: The unresolved duel between the bad and the worst
- Pages: 260-261
- First Published: 04 December 2021